LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.Armin Bender, Elke Jäger, S. Al-Batran et al.|PubMed|2007Cited by 53
LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancersArmin Bender, Elke Jäger, Julia Karbach et al.|Cancer Cell International|2004Cited by 2